The world's first independent laboratory devoted solely to the development of an linkurl:AIDS;http://www.the-scientist.com/article/display/53516/ vaccine opens today (Nov. 12) in Brooklyn, New York. The new facility represents a new front in the effort to create an AIDS vaccine after recent, high profile clinical trial linkurl:failures;http://www.the-scientist.com/blog/display/54838/ of vaccine candidates. The linkurl:International AIDS Vaccine Initiative's;http://www.the-scientist.com/blog/display/53947/ (IAVI) AIDS Vaccine Design and Development Laboratory will be the first lab to take residence in the New York Science Center, or BioBAT, which takes its name from the sprawling linkurl:Brooklyn Army Terminal,;http://www.brooklynarmyterminal.com/ in which it is nestled. The approximately 38,000 square foot linkurl:BSL3;http://www.the-scientist.com/blog/display/55166/ lab will initially focus on developing replicating vectors for an AIDS vaccine. "What they're trying to do is look at a whole range of replicating vectors and running them through a sieve," evaluating their safety, specificity, stability, and ability to transport an antigen, IAVI president linkurl:Seth Berkeley;http://www.the-scientist.com/article/display/12461/ told __The Scientist__. The lab, Berkley said,...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!